We also used GW486936–39, an inhibitor of EVs generation, to assess whether inhibition of EVs generation can attenuate sevoflurane-induced tau trafficking and IL-6 generation in vitro, and cognitive impairment in mice. The gene discussed is MAPT; the disease is Cognitive impairment.